Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. Inst. Med. Trop. Säo Paulo ; 43(3): 153-159, May-June 2001. ilus, tab
Artigo em Inglês | LILACS | ID: lil-298906

RESUMO

The circumoval precipitin test (COPT), enzyme-linked immunosorbent assay (ELISA) and the immunoblotting anti-adult worm antigen (AWA) and soluble egg antigen (SEA) tests were applied to 17 chronically schistosome-infected patients for the detection of anti-Schistosoma mansoni antibodies before and on four occasions after oxamniquine administration over a period of six months. Compared to a control group, schistosomiasis patients showed high levels of IgG antibodies in AWA and SEA-ELISA. A decrease in IgG levels was observed six months after treatment, although negative reactions were not obtained. Significant decreases in IgG1, IgG3 and, mainly, IgG4, but not anti-SEA IgG2 levels were observed six months after treatment, again without negativity. Analysis of anti-AWA IgG antibodies by immunoblotting before treatment showed a 31 kDa strand in 14 patients (82 percent) which disappeared in three cases up to six months after treatment; furthermore, anti-SEA IgG antibodies showed the same band in nine patients (53 percent) before treatment, which disappeared in only four cases up to six months after treatment


Assuntos
Humanos , Animais , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Anticorpos Anti-Helmínticos/sangue , Imunoglobulina G/sangue , Schistosoma mansoni/imunologia , Esquistossomose mansoni/imunologia , Análise de Variância , Antígenos de Helmintos , Doença Crônica , Ensaio de Imunoadsorção Enzimática , Estudo de Avaliação , Seguimentos , Immunoblotting , Oxamniquine/uso terapêutico , Esquistossomose mansoni/tratamento farmacológico , Esquistossomicidas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA